|
Originally published In Press as doi:10.1074/jbc.M402486200 on April 15, 2004
J. Biol. Chem., Vol. 279, Issue 29, 30419-30424, July 16, 2004
Human Nucleotide Excision Repair Efficiently Removes Chromium-DNA Phosphate Adducts and Protects Cells against Chromate Toxicity*
Mindy Reynolds,
Elizabeth Peterson,
George Quievryn, and
Anatoly Zhitkovich
From the
Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island 02912
Intracellular reduction of carcinogenic Cr(VI) leads to the extensive formation of Cr(III)-DNA phosphate adducts. Repair mechanisms for chromium and other DNA phosphate-based adducts are currently unknown in human cells. We found that nucleotide excision repair (NER)-proficient human cells rapidly removed chromium-DNA adducts, with an average t of 7.1 h, whereas NER-deficient XP-A, XP-C, and XP-F cells were severely compromised in their ability to repair chromium-DNA lesions. Activation of NER in Cr(VI)-treated human fibroblasts or lung epithelial H460 cells was manifested by XPC-dependent binding of the XPA protein to the nuclear matrix, which was also observed in UV light-treated (but not oxidant-stressed) cells. Intracellular replication of chromium-modified plasmids demonstrated increased mutagenicity of binary Cr(III)-DNA and ternary cysteine-Cr(III)-DNA adducts in cells with inactive NER. NER deficiency created by the loss of XPA in fibroblasts or by knockdown of this protein by stable expression of small interfering RNA in H460 cells increased apoptosis and clonogenic death by Cr(VI), providing genetic evidence for the role of monofunctional chromium-DNA adducts in the toxic effects of this metal. The rate of NER of chromium-DNA adducts under saturating conditions was calculated to be 50,000 lesions/min/cell. Because chromium-DNA adducts cause only small changes in the DNA helix, rapid repair of these modifications in human cells indicates that the presence of major structural distortions in DNA is not required for the efficient detection of the damaged sites by NER proteins in vivo.
Received for publication, March 4, 2004
, and in revised form, April 12, 2004.
* This work was supported by National Institutes of Health Grants 2R01 ES008786, 5T32 ES007272, and 1P20 RR015578. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pathology and Laboratory Medicine, Brown University, 69 Brown St., P. O. Box G-B511, Providence, RI 02912. Tel.: 401-863-2912; Fax; 401-863-9008; E-mail: Anatoly_Zhitkovich{at}brown.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. A. Nemec and A. Barchowsky
Signal Transducer and Activator of Transcription 1 (STAT1) is Essential for Chromium Silencing of Gene Induction in Human Airway Epithelial Cells
Toxicol. Sci.,
July 1, 2009;
110(1):
212 - 223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Reynolds, E. C. Peterson-Roth, I. A. Bespalov, T. Johnston, V. M. Gurel, H. L. Menard, and A. Zhitkovich
Rapid DNA Double-Strand Breaks Resulting from Processing of Cr-DNA Cross-Links by Both MutS Dimers
Cancer Res.,
February 1, 2009;
69(3):
1071 - 1079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Branco, A. P. Chung, T. Johnston, V. Gurel, P. Morais, and A. Zhitkovich
The Chromate-Inducible chrBACF Operon from the Transposable Element TnOtChr Confers Resistance to Chromium(VI) and Superoxide
J. Bacteriol.,
November 1, 2008;
190(21):
6996 - 7003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Brooks, T. J. O'Brien, S. Ceryak, J. P. Wise Sr, S. S. Wise, J. P. Wise Jr, E. DeFabo, and S. R. Patierno
Excision repair is required for genotoxin-induced mutagenesis in mammalian cells
Carcinogenesis,
May 1, 2008;
29(5):
1064 - 1069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schnekenburger, G. Talaska, and A. Puga
Chromium Cross-Links Histone Deacetylase 1-DNA Methyltransferase 1 Complexes to Chromatin, Inhibiting Histone-Remodeling Marks Critical for Transcriptional Activation
Mol. Cell. Biol.,
October 15, 2007;
27(20):
7089 - 7101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Reynolds and A. Zhitkovich
Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53
Carcinogenesis,
July 1, 2007;
28(7):
1613 - 1620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ziaee, J. Daniel, A. K. Datta, S. Blunt, and D. J. W. McMinn
Transplacental transfer of cobalt and chromium in patients with metal-on-metal hip arthroplasty: A CONTROLLED STUDY
J Bone Joint Surg Br,
March 1, 2007;
89-B(3):
301 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Daniel, H. Ziaee, C. Pradhan, P. B. Pynsent, and D. J. W. McMinn
Blood and urine metal ion levels in young and active patients after Birmingham hip resurfacing arthroplasty: FOUR-YEAR RESULTS OF A PROSPECTIVE LONGITUDINAL STUDY
J Bone Joint Surg Br,
February 1, 2007;
89-B(2):
169 - 173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Reynolds, L. Stoddard, I. Bespalov, and A. Zhitkovich
Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair
Nucleic Acids Res.,
January 28, 2007;
35(2):
465 - 476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Quievryn, J. Messer, and A. Zhitkovich
Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate
Carcinogenesis,
November 1, 2006;
27(11):
2316 - 2321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-E. Wang, Q. Zhu, G. Wani, M. A. El-Mahdy, J. Li, and A. A. Wani
DNA repair factor XPC is modified by SUMO-1 and ubiquitin following UV irradiation
Nucleic Acids Res.,
July 19, 2005;
33(13):
4023 - 4034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Sumner, A. Shanmuganathan, T. C. Sideri, S. A. Willetts, J. E. Houghton, and S. V. Avery
Oxidative protein damage causes chromium toxicity in yeast
Microbiology,
June 1, 2005;
151(6):
1939 - 1948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Peterson-Roth, M. Reynolds, G. Quievryn, and A. Zhitkovich
Mismatch Repair Proteins Are Activators of Toxic Responses to Chromium-DNA Damage
Mol. Cell. Biol.,
May 1, 2005;
25(9):
3596 - 3607.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|